Activated protein C resistance in the Japanese population due to homozygosity for the factor v R2 haplotype

International Journal of Hematology

Volumn 91, Issue 3, 2010, Pages 549-550

  Okada, Hiromi ^a,b   Toyoda, Yoshimi ^c   Takagi, Akira ^c   Saito, Hidehiko ^d   Kojima, Tetsuhito ^c   Yamazaki, Tomio ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d NAGOYA CENTRAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; GENOMIC DNA;

ACTIVATED PROTEIN C RESISTANCE; DEEP VEIN THROMBOSIS; GENE FREQUENCY; HAPLOTYPE; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; JAPANESE; LETTER; LEUKOCYTE; MUTATIONAL ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; PHENOTYPE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PROTEIN C DEFICIENCY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VENOUS BLOOD;

ACTIVATED PROTEIN C RESISTANCE; ASIAN CONTINENTAL ANCESTRY GROUP; FACTOR V; HAPLOTYPES; HOMOZYGOTE; HUMANS; JAPAN; PROTEIN C; RISK FACTORS;

EID: 77950878415     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0547-3     Document Type: Letter

References (8)

1. B Dahlbäck 1999 Procoagulant and anticoagulant properties of coagulation factor V: factor V Leiden (APC resistance) causes hypercoagulability by dual mechanisms J Lab Clin Med 133 415 422 10.1016/S0022-2143(99)90018-5 10235124 (Pubitemid 29212164)
2. F Bernardi EM Faioni E Castoldi B Lunghi G Astaman E Sacchi, et al. 1997 A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype Blood 90 1552 1557 1:CAS:528: DyaK2sXltlOku7Y%3D 9269773 (Pubitemid 27355427)
3. MCH De Visser JF Guasch PW Kamphuisen HL Vos FR Rosendaal RM Bertina 2000 The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis Thromb Haemost 83 577 582 10780320
4. Brugge J, Yamazaki T, Tans G, Dahlbäck B, Rosing J, Nicolaes GAF. Functional characterization of recombinant factor V molecules mimicking the R2-haplotype. XIXth congress of the International Society on Thrombosis and Haemostasis, Birmingham, England. (abstract: OC258 Available at: http://www.blackwellpublishing.com/isth2003/ ).
5. B Dahlbäck M Carlsson PJ Svensson 1993 Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C Proc Natl Acad Sci USA 90 1004 1008 10.1073/pnas.90.3.1004 8430067 (Pubitemid 23053939)
6. RM Bertina BP Koeleman T Koster, et al. 1994 Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 64 67 10.1038/369064a0 1:CAS:528:DyaK2cXktVKnt7c%3D 8164741 (Pubitemid 24144355)
7. O Takamiya F Ishida H Kodaira K Kitano 1995 APC-resistance and Mnl genotype (Gln 506) of coagulation factor V are rare in Japanese population Thromb Haemost 74 996 1:CAS:528:DyaK2MXot1Ohsbo%3D 8571340
8. H Fujimura J Kambayashi M Monden H Kato T Miyata 1996 Coagulation factor V Leiden mutation may have a racial background Thromb Haemost 75 859 860